EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Impact of Coexisting Adenomyosis on the Histopathological, Immunohistochemical, and Molecular Features of Endometrial Cancer and on Adjuvant Therapy Allocation: A Single‐Center Retrospective Cohort Study

Marco D'Asta, Caterina Monaco, Ferdinando Antonio Gulino iD, Carla Ettore iD, Giosuè Giordano Incognito iD, Giuseppe Ettore iD

Obstetrics and Gynecology International · 2026-01 · 2026 (1)

DOI: 10.1155/ogi/3792144 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Obstetrics and Gynecology International, online erschienen am 08.11.2026. Verfasst von Marco D'Asta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynecology Unit Maternal Child Department ARNAS Garibaldi Nesima Catania Italy. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Adenomyosis is frequently found in hysterectomy specimens of women with endometrial cancer (EC), but its relationship with tumor characteristics remains debated. This study aimed to compare the histopathological, immunohistochemical (IHC) and molecular features of EC, and the allocation of adjuvant therapy, between patients with and without coexisting adenomyosis.

Methods

Single‐center retrospective cohort study of consecutive women who underwent hysterectomy for EC at ARNAS Garibaldi Nesima, Catania, Italy, between January 2023 and September 2024, with complete IHC and molecular profiling. Adenomyosis was defined histopathologically. FIGO 2023 stage, histotype and grade, myometrial invasion, lymphovascular space invasion (LVSI), nodal status, p53 and p16 expression, POLE, mismatch repair (MMR), KRAS and PIK3CA status, and adjuvant therapy were compared using Fisher’s exact and chi‐square tests, with odds ratio (OR) and 95% confidence interval (CI).

Results

Of 87 patients, 27 (31.0%) had coexisting adenomyosis. Adenomyosis was associated with FIGO stage I (81.5% vs. 46.7%; OR 5.03, 95% CI 1.68–15.04; p = 0.003), myometrial invasion < 50% (66.7% vs. 35.0%; OR 3.71, 95% CI 1.42–9.70; p = 0.010), absent/focal LVSI (77.8% vs. 50.0%; OR 3.50, 95% CI 1.24–9.89; p = 0.019) and a lower proportion of grade 3 endometrioid tumors (3.7% vs. 26.7%; p = 0.017). No differences were observed in nodal status or in p53, p16, POLE, MMR, KRAS, or PIK3CA status. Fewer patients with adenomyosis received adjuvant therapy (29.6% vs. 58.3%; OR 0.30, 95% CI 0.11–0.80; p = 0.020). Multivariable adjustment was not feasible given the sample size.

Conclusion

In this cohort, coexisting adenomyosis was associated with earlier‐stage, less invasive EC and, consistently, with less frequent allocation to adjuvant therapy. These are univariate associations from a small, single‐center retrospective series without survival data; they do not establish an independent or causal effect of adenomyosis and require confirmation in larger prospective multicenter studies.

Schlagwörter

Stichwörter der Autor:innen

adenomyosisadjuvant therapyendometrial neoplasmsmolecular classificationneoplasm stagingretrospective cohort study

Autor:innen und Institutionen

  • Obstetrics and Gynecology Unit Maternal Child Department ARNAS Garibaldi Nesima Catania Italy.
  • Unit of Gynecology and Obstetrics Department of Human Pathology of Adults and Developmental Age "G. Martino" University Hospital Messina Italy.

ORCID-Profile: Ferdinando Antonio Gulino, Carla Ettore, Giosuè Giordano Incognito, Giuseppe Ettore

Zitieren

APA

D'Asta, M., Monaco, C., Gulino, F. A., Ettore, C., Incognito, G. G., & Ettore, G. (2026). Impact of Coexisting Adenomyosis on the Histopathological, Immunohistochemical, and Molecular Features of Endometrial Cancer and on Adjuvant Therapy Allocation: A Single‐Center Retrospective Cohort Study. Obstetrics and Gynecology International, 2026(1). https://doi.org/10.1155/ogi/3792144

Vancouver

D'Asta M, Monaco C, Gulino FA, Ettore C, Incognito GG, Ettore G. Impact of Coexisting Adenomyosis on the Histopathological, Immunohistochemical, and Molecular Features of Endometrial Cancer and on Adjuvant Therapy Allocation: A Single‐Center Retrospective Cohort Study. Obstetrics and Gynecology International. 2026;2026(1). doi:10.1155/ogi/3792144

BibTeX
@article{DAsta2026,
  author = {D'Asta, Marco and Monaco, Caterina and Gulino, Ferdinando Antonio and Ettore, Carla and Incognito, Giosuè Giordano and Ettore, Giuseppe},
  title = {Impact of Coexisting Adenomyosis on the Histopathological, Immunohistochemical, and Molecular Features of Endometrial Cancer and on Adjuvant Therapy Allocation: A Single‐Center Retrospective Cohort Study},
  journal = {Obstetrics and Gynecology International},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ogi/3792144}
}
Kostenlos starten →